Introduction The world is facing the COVID-19 pandemic. The development of a vaccine is
challenging. We aimed to determine the proportion of people who intend to get vaccinated …

Background The antiviral efficacy of remdesivir against SARS-CoV-2 is still controversial.
We aimed to evaluate the clinical efficacy of remdesivir plus standard of care compared with …

The passe sanitaire increased levels of vaccination, but to a lower extent among the most
vulnerable, and did not reduce vaccine hesitancy itself, showing the importance of outreach …

For the first 3 months of COVID-19 pandemic, COVID-19 was expected to be an immunizing
non-relapsing disease. We report a national case series of 11 virologically-confirmed COVID…

Understanding the immune responses elicited by SARS-CoV-2 infection is critical in terms
of protection against reinfection and, thus, for public health policy and vaccine development …

Background Despite improvements in medical and surgical therapy, infective endocarditis (IE)
is still associated with a severe prognosis and remains a therapeutic challenge. We aimed …

Background On 7 February 2020, French Health authorities were informed of a confirmed
case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an Englishman …

A 64-year-old man without medical history was admitted to our hospital after he fell and hurt
his left shoulder leading to a tear of the rotator cuff. He had fever and cough for two days. In …

Hydroxychloroquine (HCQ) appears to be a promising treatment for COVID-19. However, all
ongoing clinical trials with HCQ use different dosing regimens, resulting in various …

Background Despite the availability of effective vaccines against COVID-19, booster
vaccinations are needed to maintain vaccine-induced protection against variant strains and …